SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Hutchmed (China)
HCM
Halozyme Therapeutics
HALO
(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 16.64%167.48M | 18.50%654.95M | 17.68%164.8M | 15.81%187.02M | 20.08%159.54M | 21.37%143.59M | 28.72%552.69M | 26.18%140.04M | 31.72%161.48M | 28.91%132.86M |
Operating revenue | 16.04%154M | 16.09%602.39M | 16.68%150.47M | 14.07%171.97M | 17.80%147.23M | 16.24%132.71M | 21.51%518.87M | 17.56%128.97M | 23.38%150.76M | 21.66%124.98M |
Cost of revenue | 15.26%59.22M | 19.29%223.24M | 19.71%58M | 19.08%58.74M | 19.36%55.13M | 18.97%51.38M | 11.27%187.14M | 20.11%48.45M | 19.84%49.32M | 12.42%46.18M |
Gross profit | 17.40%108.26M | 18.10%431.71M | 16.60%106.8M | 14.38%128.28M | 20.46%104.42M | 22.75%92.21M | 39.95%365.55M | 29.64%91.6M | 37.72%112.16M | 39.84%86.68M |
Operating expense | 6.00%122.51M | 3.61%487.16M | -2.51%120.16M | 0.53%120.83M | 10.44%130.59M | 6.52%115.58M | 17.31%470.21M | 22.31%123.26M | 14.57%120.19M | 23.50%118.25M |
Selling and administrative expenses | 3.50%105.09M | 2.36%425.75M | -4.04%104.53M | -0.72%105.76M | 9.15%113.93M | 5.64%101.53M | 16.29%415.94M | 24.13%108.93M | 11.46%106.53M | 22.59%104.37M |
-Selling and marketing expense | 7.60%56.79M | 5.17%223.05M | 0.34%56.68M | 0.61%55.84M | 11.25%57.75M | 9.51%52.78M | 24.30%212.09M | 32.37%56.49M | 33.77%55.5M | 27.61%51.91M |
-General and administrative expense | -0.93%48.3M | -0.57%202.7M | -8.76%47.85M | -2.18%49.92M | 7.08%56.17M | 1.75%48.75M | 8.98%203.85M | 16.32%52.45M | -5.65%51.03M | 17.99%52.46M |
Research and development costs | 24.00%17.43M | 13.19%61.42M | 9.10%15.63M | 10.32%15.07M | 20.11%16.67M | 13.33%14.06M | 25.78%54.26M | 10.05%14.33M | 46.48%13.66M | 30.83%13.88M |
Operating profit | 39.01%-14.25M | 47.02%-55.45M | 57.81%-13.36M | 192.84%7.46M | 17.09%-26.18M | 30.00%-23.37M | 25.04%-104.66M | -5.11%-31.67M | 65.77%-8.03M | 6.50%-31.57M |
Net non-operating interest income expense | 8.52%-1.14M | -0.95%-4.68M | 3.23%-1.14M | 41.83%-1.15M | -185.40%-1.15M | -14.44%-1.24M | -757.30%-4.64M | -1,165.59%-1.18M | -1,850.50%-1.97M | -260.71%-404K |
Non-operating interest expense | -8.52%1.14M | 0.95%4.68M | -3.23%1.14M | -41.83%1.15M | 185.40%1.15M | 14.44%1.24M | 757.30%4.64M | 1,165.59%1.18M | 1,850.50%1.97M | 260.71%404K |
Other net income (expense) | 79.38%1.67M | -90.97%418K | -95.32%99K | -43.43%1.13M | -2,743.94%-1.75M | 109.21%931K | 194.90%4.63M | 6,953.33%2.12M | 16,791.67%2M | -79.88%66K |
Other non- operating income (expenses) | 79.38%1.67M | -90.97%418K | -95.32%99K | -43.43%1.13M | -2,743.94%-1.75M | 109.21%931K | 194.90%4.63M | 6,953.33%2.12M | 16,791.67%2M | -79.88%66K |
Income before tax | 42.06%-13.72M | 42.95%-59.72M | 53.13%-14.4M | 193.06%7.44M | 8.88%-29.07M | 30.40%-23.69M | 24.48%-104.66M | -1.78%-30.73M | 66.07%-8M | 4.89%-31.91M |
Income tax | -108.42%-6.44M | 93.25%-773K | 384.77%3.89M | 289.97%1.25M | 36.45%-2.82M | 37.97%-3.09M | 62.56%-11.45M | 78.56%-1.37M | 90.43%-658K | 45.03%-4.44M |
Net income | 64.63%-7.28M | 36.77%-58.94M | 37.70%-18.29M | 184.37%6.19M | 4.42%-26.25M | 29.11%-20.6M | 13.70%-93.22M | -23.26%-29.36M | 56.04%-7.34M | -7.85%-27.46M |
Net income continuous Operations | 64.63%-7.28M | 36.77%-58.94M | 37.70%-18.29M | 184.37%6.19M | 4.42%-26.25M | 29.11%-20.6M | 13.70%-93.22M | -23.26%-29.36M | 56.04%-7.34M | -7.85%-27.46M |
Minority interest income | 0 | 0 | ||||||||
Net income attributable to the parent company | 64.63%-7.28M | 36.77%-58.94M | 37.70%-18.29M | 184.37%6.19M | 4.42%-26.25M | 29.11%-20.6M | 22.09%-93.22M | -23.26%-29.36M | 56.04%-7.34M | -7.85%-27.46M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 64.63%-7.28M | 36.77%-58.94M | 37.70%-18.29M | 184.37%6.19M | 4.42%-26.25M | 29.11%-20.6M | 22.09%-93.22M | -23.26%-29.36M | 56.04%-7.34M | -7.85%-27.46M |
Basic earnings per share | 66.67%-0.04 | 37.74%-0.33 | 41.18%-0.1 | 175.00%0.03 | 6.25%-0.15 | 29.41%-0.12 | 23.19%-0.53 | -21.43%-0.17 | 60.00%-0.04 | -6.67%-0.16 |
Diluted earnings per share | 66.67%-0.04 | 37.74%-0.33 | 41.18%-0.1 | 175.00%0.03 | 6.25%-0.15 | 29.41%-0.12 | 23.19%-0.53 | -21.43%-0.17 | 60.00%-0.04 | -6.67%-0.16 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |